Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance ...

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of ...

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Clinical Account Manager

Daxor Corporation is seeking a driven professional with a clinical background and a passion for sales to manage and grow a portfolio of clinical accounts. This high-impact, sales-driven position involves working closely with prescribers and care teams to drive adoption of Daxor’s Blood Volume Analysis technology in hospital and outpatient settings.

Sign up with Google

Sign in with Google